Clinical Trials Browser

OTHER × Adenosine Diphosphate Ribose × Gynecologic × Clear all

NCT05494580 2026-03-10

Pamiparib Plus Surufatinib in Patients With Platinum-resistant Ovarian Cancer

Phase 1/2 Completed

Ovarian Neoplasms

NCT06063070 2023-10-02

First-line Maintenance Treatment With Fluzoparib Plus Bevacizumab in Advanced BRCA Wild Type Ovarian Cancer

Phase 2 Not yet recruiting

Fallopian Tube Neoplasms, Ovarian Neoplasms